| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/31/2008 | US20080026080 Reacting a gluconic acid with lactic acid in the presence of calcium hydroxide and water to obtain a calcium gluconolactate molecule having the formula HO-CH2-(CHOH)4-COO-Ca-OOC-CH(-OH)-CH3 with molecular weight of 324.2994; physical and chemical properties; nutraceuticals |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026070 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 01/31/2008 | US20080026069 Particles |
| 01/31/2008 | US20080026068 Pulmonary delivery of spherical insulin microparticles |
| 01/31/2008 | US20080026067 Method for Increasing Specific Surface Area of Slightly Soluble Drug |
| 01/31/2008 | US20080026066 Liquids Containing Suspended Glass Particles |
| 01/31/2008 | US20080026065 Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State |
| 01/31/2008 | US20080026064 Cell-polymer fiber compositions and uses thereof |
| 01/31/2008 | US20080026063 Composition containing reduced coenzyme Q10 and production method thereof |
| 01/31/2008 | US20080026062 Pharmaceutical compositions including nano-sized active agent |
| 01/31/2008 | US20080026061 Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
| 01/31/2008 | US20080026060 Controlled-release pharmaceutical tablets |
| 01/31/2008 | US20080026059 Methods of Reducing Degradant Formation in Pharmaceutical Compositions of Varenicline |
| 01/31/2008 | US20080026058 Methods for treating and preventing mucositis |
| 01/31/2008 | US20080026057 Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition |
| 01/31/2008 | US20080026056 Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form |
| 01/31/2008 | US20080026055 Chewable tablet containing phenylephrine |
| 01/31/2008 | US20080026054 Novel anelgesic combination |
| 01/31/2008 | US20080026053 Capsule containing granular pharmaceutical compositions |
| 01/31/2008 | US20080026052 Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats |
| 01/31/2008 | US20080026051 Pharmaceutical form having a two-layer separating layer |
| 01/31/2008 | US20080026050 Solid dose formulations of a thrombin receptor antagonist |
| 01/31/2008 | US20080026049 Liposomal compositions for parenteral delivery of agents |
| 01/31/2008 | US20080026048 Reovirus for the treatment of cellular proliferative disorders |
| 01/31/2008 | US20080026047 Cancer Detection Reagents And Uses In Pathology And Diagnostics And Cancer Cell Death |
| 01/31/2008 | US20080026046 Stable Aqueous G-Csf Conatining Compositions |
| 01/31/2008 | US20080026045 Combination Chemotherapy Comprising a Gemcitabine and a Liposomal Platium Complex |
| 01/31/2008 | US20080026044 Combination Chemotherapy Comprising Capecitabine and a Liposomal Platinum Complex |
| 01/31/2008 | US20080026043 Transdermal Therapeutic System Comprising an Adhesive Layer Method for Siliconizing the Back Layer or the System and Use of Said Back Layer |
| 01/31/2008 | US20080026042 Preoperative Treatment of Post Operative Pain |
| 01/31/2008 | US20080026041 Non-woven media incorporating ultrafine or nanosize powders |
| 01/31/2008 | US20080026040 Active agent-releasing dosage forms |
| 01/31/2008 | US20080026039 Benzoyl peroxide pads and formulations therefor |
| 01/31/2008 | US20080026038 No laxation, low flatulence bulking system |
| 01/31/2008 | US20080026037 Compositions Comprising Strontium and Vitamin D and Uses Thereof |
| 01/31/2008 | US20080026036 Method of feeding a ruminant |
| 01/31/2008 | US20080026035 Method Of Treating Atrophic Vaginitis |
| 01/31/2008 | US20080026031 Implantable polymeric device for sustained release of buprenorphine |
| 01/31/2008 | US20080026030 Corneal Epithelial Sheet and Process for Producing the Same |
| 01/31/2008 | US20080026022 Process for the preparation of stable polymer concentrates |
| 01/31/2008 | US20080026021 Delivery system for an oral care substance |
| 01/31/2008 | US20080026016 Aqueous Dispersions of Low-Water Solubility or Water-Insoluble Active Substances and Dry Powders Produced Therefrom |
| 01/31/2008 | US20080026014 Nasal Stick for the Application of Medicaments and Skin Care Substances |
| 01/31/2008 | US20080026013 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080025987 Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix |
| 01/31/2008 | US20080025963 Compositions and methods for the treatment of CNS injuries |
| 01/31/2008 | US20080025928 Delivery system for an oral care substance |
| 01/31/2008 | US20080025927 Delivery system for an oral care substance |
| 01/31/2008 | US20080025924 Delivery system for an oral care substance |
| 01/31/2008 | US20080025923 Delivery system for an oral care substance |
| 01/31/2008 | US20080025921 Conductance of Improperly Folded Proteins Through the Secretory Pathway And Related Methods For Treating Disease |
| 01/31/2008 | US20080025920 Methods of treating hot flashes with formulations for transdermal or transmucosal application |
| 01/31/2008 | US20080025919 Benzoylguanidine salt and hydrates thereof |
| 01/31/2008 | US20080023859 Glycopeptides and Temperature-Responsive Micelles |
| 01/31/2008 | DE102006035549A1 Arzneiform mit mindestens zweischichtiger Trennschicht Dosage form with at least two-layer separation layer |
| 01/31/2008 | CA2842219A1 Inhibition of marcks-mediated degranulation by marcks n-terminal peptides in treating inflammation |
| 01/31/2008 | CA2659322A1 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | CA2659245A1 Anti-migraine oral spray formulations and methods |
| 01/31/2008 | CA2659147A1 Granulated sorbitol and method for the preparation thereof |
| 01/31/2008 | CA2659026A1 Pharmaceutical form with multilayer separating layer |
| 01/31/2008 | CA2658915A1 Coating composition comprising starch |
| 01/31/2008 | CA2658646A1 Ophthalmic solutions |
| 01/31/2008 | CA2658629A1 Chewable tablet containing phenylephrine |
| 01/31/2008 | CA2658518A1 Cyclosporin compositions |
| 01/31/2008 | CA2658512A1 Orally dissolvable/disintegrable lyophilized dosage forms containing protected particles |
| 01/31/2008 | CA2658493A1 Pharmaceutical formulation comprising donepezil |
| 01/31/2008 | CA2658436A1 A novel lactic acid formulation of mk-0457 useful for the treatment of cancer |
| 01/31/2008 | CA2658314A1 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 01/31/2008 | CA2658121A1 Delivery system and method of manufacturing the same |
| 01/31/2008 | CA2658109A1 High dose orally dissolvable/disintegrable lyophilized dosage form |
| 01/31/2008 | CA2657817A1 Caspofungin formulations |
| 01/31/2008 | CA2657202A1 Extended release pharmaceutical formulation of metoprolol and process for its preparation |
| 01/31/2008 | CA2656974A1 Thermochromic compositions for skin application |
| 01/31/2008 | CA2628574A1 Polypeptide films and methods |
| 01/30/2008 | EP1882480A2 High glycerin containing anti-microbial cleansers |
| 01/30/2008 | EP1881847A2 Injection solution for rna |
| 01/30/2008 | EP1881839A2 Compositions of bakuchiol and methods of making the same |
| 01/30/2008 | EP1881836A1 Method for preparing and using water-based steroid pheromone compositions |
| 01/30/2008 | EP1881831A1 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof |
| 01/30/2008 | EP1881821A2 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures |
| 01/30/2008 | EP1881820A2 Disposable dispenser for patient infusion |
| 01/30/2008 | EP1881819A1 Extrusion process for making compositions with poorly compressible therapeutic compounds |
| 01/30/2008 | EP1881818A1 Composition for treatment of a detached retina and method of production thereof |
| 01/30/2008 | EP1784238A4 Counter pressure device for ophthalmic drug delivery |
| 01/30/2008 | EP1332220B1 Oligonucleotide - facilitated coalescence |
| 01/30/2008 | CN201012180Y Conjunctiva sac medicament sustained release film |
| 01/30/2008 | CN101115547A Mixing apparatus |
| 01/30/2008 | CN101115478A A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an HMG-CoA reductase inhibitor |
| 01/30/2008 | CN101115475A Compositions and methods for treating conditions of the nail unit |
| 01/30/2008 | CN101115474A Composite structure including a low vinyl acetate layer |
| 01/30/2008 | CN101115473A Confectionery products containing caffeine |
| 01/30/2008 | CN101115472A Molecules enhancing dermal delivery of influenza vaccines |
| 01/30/2008 | CN101115471A Polymer particle delivery compositions and methods of use |
| 01/30/2008 | CN101115470A Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers |
| 01/30/2008 | CN101115469A Quick disintegration tablet and method of producing the same |
| 01/30/2008 | CN101115468A Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
| 01/30/2008 | CN101115467A Analgesic compositions |
| 01/30/2008 | CN101115465A Personal care compositions |